Update Course Rewind 2025: Botox for Hirschsprung’s: Where, When, and Why

Timing: Concurrent Injection Versus Staged Approach

The first decision is whether to inject Botox during the pull-through itself or reserve it for postoperative management 0:33 0:42 0:45. Practice is split: 50% of polled surgeons do not inject at the time of surgery 0:33. The Cincinnati Children's group injects concurrently 0:42, and a 2022 multi-center study found that 24% of patients undergoing pull-through received Botox 0:45. The argument for concurrent injection is efficiency and the potential to preempt early complications 0:42 0:55. The argument against is that it adds a technical step to an already complex operation and commits to an intervention before the postoperative course declares itself 0:33. This is not a question with a consensus answer — it is a question about how aggressively you want to manage sphincter tone in the immediate postoperative period 0:33 0:42.

The Enterocolitis Reduction Signal

The Cincinnati data from 2020 to 2024 showed a striking difference in early enterocolitis: 0% in patients who received Botox versus 30% in those who did not, measured within 31 days after pull-through 0:55. That is a large effect size in a high-stakes outcome 0:55. The mechanism is straightforward — Botox reduces internal sphincter tone, theoretically improving emptying and reducing stasis that predisposes to bacterial overgrowth and mucosal injury 0:55. The trade-off is predictable: patients who received Botox had a higher chance of diaper rash 1:09, the clinical manifestation of reduced sphincter resistance. The question is whether you accept more frequent diaper rash to eliminate early enterocolitis, or whether you reserve Botox for patients who declare themselves at risk postoperatively 0:55 1:09. The Cincinnati approach suggests the former is worth it 0:55.

Dosing: No Standard Exists

"The number of units is challenging because there's no evidence on it" [q3]. One of the discussants stated plainly that better data is needed 1:23. There is no evidence on the number of units of Botox to use 1:20. This is not a minor gap — dosing determines both efficacy and duration of effect 1:20 1:23. Too little and you may not achieve meaningful sphincter relaxation; too much and you risk prolonged incontinence beyond the window where it is clinically useful 1:20. The absence of dose-response data means every center is operating on local experience rather than shared evidence 1:23. Weight-based dosing, fixed dosing, and empiric adjustments based on sphincter thickness are all in use, but none are validated 1:20 1:23.

Ultrasound Guidance: Precision Versus Pragmatism

One discussant uses ultrasound guidance routinely: "I can see every layer where the needle is, how much I put where, and where it diffuses to" [q6]. Ultrasound allows visualization of every layer, needle position, injection amount and location, and diffusion pattern 1:25. The advantage is precision — you know you are in the internal sphincter and not the external sphincter or perirectal fat 1:25. The disadvantage is that it requires equipment, time, and comfort with ultrasound-guided injection technique 1:25. The alternative is anatomic landmark-based injection, which is faster but less certain 1:25. For a toxin that works by local diffusion, knowing where it goes matters 1:25. Whether that precision changes outcomes is unknown, but the logic is sound: if you are going to inject, inject where you intend to 1:25.

The Central Tension

The discussants emphasized that injecting Botox during pull-through for Hirschsprung's disease has been shown to reduce enterocolitis risk 1:37, but dosing and guidance varies widely 1:41. The variation is not cosmetic — it reflects the absence of the data needed to standardize practice 1:20 1:23 1:41. Until a dose-finding study and a randomized trial of timing are completed, this will remain a judgment call informed by local results rather than shared evidence 1:23 1:41. The Cincinnati data is the strongest signal available, and it argues for concurrent injection 0:55. Whether that holds across centers with different operative techniques, different patient populations, and different thresholds for diagnosing enterocolitis is the question that remains open 1:41.